指南与共识妇科产科

黑人与西班牙裔女性较白人女性更少接受指南一致的子宫内膜癌治疗

Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
指南 / 共识 · Am J Obstet Gynecol · 2020-03-03

该研究基于美国国家癌症数据库,纳入2004-2014年89,319例子宫内膜样子宫内膜癌患者,评估种族与接受NCCN指南一致治疗的关系。结果显示,非西班牙裔黑人和西班牙裔女性接受指南一致治疗的几率低于非西班牙裔白人女性,而亚裔/太平洋岛民女性则更高。未接受指南一致治疗与总生存期较差相关,但种族分层模型可能受低统计效能影响。

要点

  • 非西班牙裔黑人和西班牙裔女性接受指南一致治疗的几率低于非西班牙裔白人女性。
  • 亚裔/太平洋岛民女性接受指南一致治疗的几率高于非西班牙裔白人女性。
  • 未接受指南一致治疗与总体人群总生存期较差相关,但种族分层模型可能受低统计效能影响。

核心结论

  • 非西班牙裔黑人和西班牙裔女性较非西班牙裔白人女性更少接受指南一致的子宫内膜癌治疗。
  • 亚裔/太平洋岛民女性更常接受指南一致治疗。
  • 总体人群中未接受指南一致治疗者总生存期较差,但种族分层模型可能受低统计效能影响。

研究设计与样本

  • 基于美国国家癌症数据库的回顾性队列研究,纳入2004-2014年89,319例侵袭性子宫内膜样子宫内膜癌女性。
  • 指南一致治疗依据美国国家综合癌症网络(NCCN)指南定义。
  • 采用多变量逻辑回归计算比值比(OR)及95%置信区间(CI),采用多变量Cox比例风险回归估计风险比(HR)及95%CI。

主要发现

  • 整体74.7%(n=66,699)接受指南一致治疗;非西班牙裔白人75.3%(n=57,442)、非西班牙裔黑人70.1%(n=4,334)、西班牙裔71.0%(n=3,263)、亚裔/太平洋岛民72.5%(n=1,660)。
  • 多变量调整后,非西班牙裔黑人(OR 0.92,95%CI 0.86-0.98)和西班牙裔女性(OR 0.90,95%CI 0.83-0.97)接受指南一致治疗的几率低于非西班牙裔白人女性。
  • 亚裔/太平洋岛民女性接受指南一致治疗的几率高于非西班牙裔白人女性(OR 1.11,95%CI 1.00-1.23)。
  • 总体人群中,未接受指南一致治疗与总生存期较差相关(HR 1.12,95%CI 1.08-1.15)。
  • 种族分层中,非西班牙裔黑人(HR 1.09,95%CI 0.98-1.21)、西班牙裔(HR 0.92,95%CI 0.78-1.09)、亚裔/太平洋岛民(HR 0.90,95%CI 0.70-1.16)未接受指南一致治疗与总生存期的关联不显著。

关键数值与推荐

  • 指南一致治疗定义依据NCCN指南。
  • 非西班牙裔黑人OR 0.92(95%CI 0.86-0.98),西班牙裔OR 0.90(95%CI 0.83-0.97),亚裔/太平洋岛民OR 1.11(95%CI 1.00-1.23),参照组为非西班牙裔白人。
  • 总体人群未接受指南一致治疗与总生存期HR 1.12(95%CI 1.08-1.15)。

临床怎么用

  • 临床应关注非西班牙裔黑人和西班牙裔子宫内膜癌患者接受指南一致治疗的机会差异。
  • 对未接受指南一致治疗的患者,需评估并干预可能影响生存的因素。
  • 未来研究应探究子宫内膜癌治疗差异的原因。

局限性

  • 种族分层模型可能受低统计效能影响。
  • 研究为回顾性数据库分析,可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Differences in receipt of guideline-concordant treatment might underlie well-established racial disparities in endometrial cancer mortality. OBJECTIVE: Using the National Cancer Database, we assessed the hypothesis that among women with endometrioid endometrial cancer, racial/ethnic minority women would have lower odds of receiving guideline-concordant treatment than white women. In addition, we hypothesized that lack of guideline-concordant treatment was linked with worse survival. STUDY DESIGN: We defined receipt of guideline-concordant treatment using the National Comprehensive Cancer Network guidelines. Multivariable logistic regression models were used to compute odds ratios and 95% confidence intervals for associations between race and guideline-concordant treatment. We used multivariable Cox proportional hazards regression models to estimate hazards ratios and 95% confidence intervals for relationships between guideline-concordant treatment and overall survival in the overall study population and stratified by race/ethnicity. RESULTS: This analysis was restricted to the 89,319 women diagnosed with an invasive, endometrioid endometrial cancer between 2004 and 2014. Overall, 74.7% of the cohort received guideline-concordant treatment (n = 66,699). Analyses stratified by race showed that 75.3% of non-Hispanic white (n = 57,442), 70.1% of non-Hispanic black (n = 4334), 71.0% of Hispanic (n = 3263), and 72.5% of Asian/Pacific Islander patients (n = 1660) received treatment in concordance with guidelines. In multivariable-adjusted models, non-Hispanic black (odds ratio, 0.92, 95% confidence interval, 0.86-0.98) and Hispanic women (odds ratio, 0.90, 95% confidence internal, 0.83-0.97) had lower odds of receiving guideline-concordant treatment compared with non-Hispanic white women, while Asian/Pacific Islander women had a higher odds of receiving guideline-concordant treatment (odds ratio, 1.11, 95% confidence interval, 1.00-1.23). Lack of guideline-concordant treatment was associated with lower overall survival in the overall study population (hazard ratio, 1.12, 95% confidence interval, 1.08-1.15) but was not significantly associated with overall survival among non-Hispanic black (hazard ratio, 1.09, 95% confidence interval, 0.98-1.21), Hispanic (hazard ratio, 0.92, 95% confidence interval=0.78-1.09), or Asian/Pacific Islander (hazard ratio, 0.90, 95% confidence interval, 0.70-1.16) women. CONCLUSION: Non-Hispanic black and Hispanic women were less likely than non-Hispanic white women to receive guideline-concordant treatment, while Asian/Pacific Islander women more commonly received treatment in line with guidelines. Furthermore, in the overall study population, overall survival was worse among those not receiving guideline-concordant treatment, although low power may have had an impact on the race-stratified models. Future studies should evaluate reasons underlying disparate endometrial cancer treatment.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kaspers M, Llamocca E, Quick A, et al. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment. Am J Obstet Gynecol. 2020. PMID: 32142825. doi:10.1016/j.ajog.2020.02.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。